Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BreathID Test for Pancreatic Exocrine Insufficiency
NCT01259544Phase 2Completed
- Sponsor
- Meridian Bioscience
- Start
- Jan 2009
- Primary completion
- Feb 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of benzoyl-L-tyrosyl-[1-13C]alanine in pancreatic exocrine insufficiency (EPI), sponsored by Meridian Bioscience. Started Jan 2009; status: completed.
02
Drugs
benzoyl-L-tyrosyl-[1-13C]alanine
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT01259544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259544.